Author:
Arumuganathan Nadhini,Wiest Maximilian Robert Justus,Toro Mario Damiano,Hamann Timothy,Fasler Katrin,Zweifel Sandrine Anne
Abstract
AbstractWhether post injectional acute intraocular pressure (IOP) increase is associated with decreased peripapillary and macular perfusion is still under debate. Here, we investigated early changes in the choroidal and retinal blood flow using OCTA imaging in a cohort of patients undergoing anti-VEGF intravitreal injections (IVI) for macular edema following retinal vein occlusion and diabetic retinopathy. In this prospective single-center, observational study, the pre- and post-IVI changes in retinal perfusion were examined via assessment of vessel length density (VLD) and vessel density (VD) in deep and superficial capillary segmentations (DCP and SCP), foveal avascular zone (FAZ) in SCP, as well as flow signal deficits in the choriocapillaris segmentation. Mean IOP significantly changed over the study course (p = 0.000; ANOVA). Measurements at 5 min post-IVI (33.48 ± 10.84 mmHg) differed significantly from baseline (17.26 ± 2.41 mmHg, p = 0.000), while measurements from one day, one week, and one-month post-IVI did not (p = 0.907, p = 1.000 and p = 1.000 respectively). In comparison to baseline, no changes in OCTA parameters, including FAZ, VD, VLD, and FV, were detected 5 min post-IVI. No significant alterations in OCTA parameters were observed during study course. Increased IOP spikes were detected post-IVI; however, no potential permanent ischemic retinal damage was suspected.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Reibaldi, M. et al. Treatment of persistent serous retinal detachment in vogt-koyanagi-harada syndrome with intravitreal bevacizumab during the systemic steroid treatment. Retina 34, 490–496 (2014).
2. Toro, M. D. et al. Early impact of covid-19 outbreak on eye care: Insights from eurocovcat group. Eur. J. Ophthalmol. 31, 5–9 (2021).
3. Plyukhova, A. A. et al. Comparative safety of bevacizumab, ranibizumab, and aflibercept for treatment of neovascular age-related macular degeneration (amd): A systematic review and network meta-analysis of direct comparative studies. J. Clin. Med. 9, 1522 (2020).
4. Ceravolo, I. et al. The application of structural retinal biomarkers to evaluate the effect of intravitreal ranibizumab and dexamethasone intravitreal implant on treatment of diabetic macular edema. Diagnostics (Basel, Switzerland) 10, 413 (2020).
5. Elfalah, M. et al. Delayed intravitreal anti-vegf therapy for patients during the covid-19 lockdown: An ethical endeavor. Clin. Ophthalmol. (Auckland, N.Z.) 15, 661–669 (2021).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献